Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsBusiness

As Airbus, Boeing cut production, Indian suppliers follow suit

Airbus informed vendors it is slashing production by half to 30 aircraft per month

May 14, 2020 / 03:36 PM IST
A320neo jets. (Source: Wikimedia Commons)

A320neo jets. (Source: Wikimedia Commons)

Aircraft manufacturers Airbus and Boeing have cut production, asking suppliers to also reduce deliveries by almost 50 percent.

In response to the coronavirus impact on the aviation industry, Airbus and Boeing have asked Indian vendors such as HAL, Dynamatic and Aequs Inc. to reduce production by one-third, the Hindu BusinessLine reported.

HAL produces doors for Airbus’ A320 aircraft and flaperons (which control a plane’s lift) for the Boeing 777 aircraft; Aequs makes 3,000 different types of products for the aircraft makers and Dynamatic supplies products for the Airbus A330 and A320.

A spokesperson for HAL told the paper the situation is being monitored and the company will make a decision on cutting production soon.

Follow our LIVE Updates on the coronavirus pandemic here

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Aravind Melligeri, Chairman and CEO of Aequs said they do not foresee any relief this year, adding that there could be layoffs.

A spokesperson for Dynamatic told BL production is being reduced by 30 percent – directly as a result of Airbus cutting production. Dynamatic is a tier-I supplier for Airbus.

Airbus, which posted $552 million loss for Q1FY21, has reportedly informed vendors it is slashing production by half to 30 aircraft per month – for which suppliers would have to pull back supplies by 40 percent.

In internal communication, CEO Guillaume Faury said the company is “bleeding cash at an unprecedented speed.” The company has shut factories in many countries including the US and has laid-off at least a dozen subcontractors.

Follow our full COVID-19 coverage here
Moneycontrol News
first published: May 14, 2020 03:36 pm

stay updated

Get Daily News on your Browser
Sections